Obesity Trial, Recruiting NCT03476551 Sponsor: Norwegian University of Science and Technology Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT03476551
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are planning to have a gastric bypass or sleeve gastrectomy (weight loss surgery) at a hospital in Central Norway
  • People who are Norwegian citizens

Who may not be able to join:

  • People who have previously had surgery where part of their digestive tract (stomach or intestines) was removed or cut away

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Magnus Strømmen, MSc, St. Olavs Hospital

Phone: 0047 72829970

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Norwegian University of Science and Technology
Registry
ClinicalTrials.gov
Start date
2 November 2016
Est. completion
1 October 2026

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Hydrochlorothiazide concentration in blood serum (area under curve (AUC))

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov